William Pridgen - 07 Jul 2021 Form 4 Insider Report for Virios Therapeutics, Inc. (DWTX)

Role
Director
Signature
/s/ Greg Duncan, Attorney-in-Fact
Issuer symbol
DWTX
Transactions as of
07 Jul 2021
Net transactions value
+$5,951
Form type
4
Filing time
09 Jul 2021, 13:36:49 UTC
Previous filing
23 Jun 2021
Next filing
22 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIRI Common Stock Purchase $5,951 +942 +0.13% $6.32* 710,734 07 Jul 2021 Direct F1, F2
holding VIRI Common Stock 3,500 07 Jul 2021 401 (k) Account F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This purchase was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021.
F2 Does not include 18,201 shares that were previously reported on the reporting person's Form 3 and prior Forms 4. Such shares were included in the person's holdings in error.
F3 The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee.